Two proven technologies.
One seamless solution.
• LigaSure™ Exact dissector
• V-Loc™ wound closure device
Patients undergoing breast procedures have enough worries. Help put their minds at ease by using trusted LigaSure™ technology which has been used in over 35 million procedures with more than 25 years of proven performance in many types of surgical procedures/specialties.†,1,2
The LigaSure™ Exact dissector may provide clinical and economic benefits for your breast procedures.
Over 50% reduction in drainage volume‡,3
Nearly 90% lymphedema reduction‡,3
Over 50% seroma reduction‡,4
Nearly 4 fewer days of hospital stay§,3
Deliver confidence. With LigaSure™ technology, you get:
The LigaSure™ Exact dissector helps to decrease lymphatic leakage, seroma, and lymphedema after total mastectomy with axillary lymph node dissection.‡,3,4
Dr. Ikeda highlights his clinical experience using LigaSure™ technology in axillary lymph node dissection procedures. (5:09)
Naoya Ikeda, M.D. Kiwa Hospital, Hashimoto City, Japan
Using the V-Loc device in breast procedures may enhance both clinical outcomes and cosmetic results.
May improve cosmetic results8
May reduce abdominal drainage by up to 55 percent in breast reconstruction procedures9
May reduce the number of total sutures used by up to 71 percent in a DIEP flap breast reconstruction procedure10
Deliver healing. With V-Loc™ wound closure device, you get:
The regulatory status of LigaSure™ Exact dissector is independent from that of V-Loc™ wound closure device.
The LigaSure™ Exact dissector is intended for use only with compatible Covidien generators. Use of this instrument with other generators may not result in the desired tissue effect, may result in injury to the patient or surgical team, or may cause damage to the instrument.
V-Loc™ absorbable wound closure device is intended to be used without the use of anchoring knots to begin or terminate the suture line. Tying knots may damage the barbs and potentially reduce their effectiveness. As with all surgical sutures, adverse effects include but are not limited to wound dehiscence, and failure to provide adequate wound support in sites where expansion, stretching, or distention occur. Refer to the V-Loc™ wound closure device instructions for use (IFU) for full safety information.
The safe and effective use of RF energy depends on many factors solely under the control of the operator. There is no substitute for properly trained and vigilant personnel. It is important that the operating instructions supplied with this or any other medical equipment be read, understood, and followed.
† Based on internal sales data from FY01-FY23. November 2023.
‡ Compared to conventional methods/electrosurgery
§ Compared to conventional electrocautery technique (5.9 vs 9.6 days, p<0.001).
◊ 22 out of 23 surgeons surveyed agreed
¶ After 5 activations
# As compared to conventional sutures.
∆ Animal data may not correlate with human clinical outcomes.
